Genmab A/S | Продажи

Name: Genmab A/S | Продажи
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

width

height

	Sales		Дата
Amgen AMGN:US	$ 6238M	608M	2022-03
AstraZeneca AZN:LN	11390M	621M	2022-03
Bayer BAYN:GR	€ 14639M	3521M	2022-03
Biomarin Pharmaceutical BMRN:US	$ 519.36M	69.55M	2022-03
Bluebird Bio BLUE:US	$ 1.94M	0.34M	2022-03
Exelixis EXEL:US	$ 355.98M	95.16M	2022-03
Fresenius Medical Care FME:GR	€ 4548.37M	98.66M	2022-03
Galapagos GLPG:NA	€ 144.03M	40.36M	2022-03
GlaxoSmithKline GSK:LN	9780M	253M	2022-03
GN Store Nord GN:DC	DK 3859M	241M	2022-03
GRIFOLS GRF:SM	€ 1351.9M	167.16M	2021-06
H. Lundbeck A/S LUN:DC	4.37B	319M	2022-03
Hikma Pharmaceutical HIK:LN	1.34B	121M	2021-12
Immunogen IMGN:US	$ 38.08M	10.09M	2022-03
Insmed INSM:US	$ 53.11M	3.02M	2022-03
Lonza Group LONN:SW	2.87B	325M	2021-12
Merck MRK:GR	€ 5198M	15M	2022-03
Novartis NOVN:VX	SF 12814M	708M	2022-03
Regeneron Pharmaceuticals REGN:US	$ 2965.1M	1986.6M	2022-03
Roche Holding ROG:VX	16.44B	474M	2022-03
Seattle Genetics SGEN:US	$ 426.46M	3.39M	2022-03
William Demant Holding WDH:DC	9.38B	364M	2021-12

Genmab A/S Продажи - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Jul 2022.